NE-100, a novel potent sigma ligand, preferentially binds to sigma 1 binding sites in guinea pig brain

Eur J Pharmacol. 1994 Jan 4;251(1):R1-2. doi: 10.1016/0014-2999(94)90453-7.

Abstract

The selectivity of N,N-dipropyl-2-[4-methoxy-3-(2-phenylethoxy)phenyl]-ethylamine monohydrochloride (NE-100) for sigma 1 and sigma 2 binding sites was studied by means of binding of [3H](+)-pentazocine and [3H]1,3-di-o-tolylguanidine ([3H]DTG) in guinea pig brain. NE-100 inhibited [3H](+)-pentazocine binding to sigma 1 binding sites potently with an IC50 value of 1.54 +/- 0.26 nM while it had a weak effect on [3H]DTG binding to sigma 2 binding sites. The inhibitory effect of NE-100 on [3H](+)-pentazocine was 55 times more potent than that on [3H]DTG binding. These results suggest that NE-100 is a potent and selective ligand for sigma 1 binding sites.

MeSH terms

  • Animals
  • Anisoles / pharmacology*
  • Binding, Competitive / drug effects
  • Brain / drug effects
  • Brain / metabolism*
  • Guanidines / pharmacokinetics
  • Guinea Pigs
  • In Vitro Techniques
  • Ligands
  • Pentazocine / pharmacokinetics
  • Propylamines / pharmacology*
  • Receptors, sigma / drug effects*

Substances

  • Anisoles
  • Guanidines
  • Ligands
  • Propylamines
  • Receptors, sigma
  • N,N-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride
  • 1,3-ditolylguanidine
  • Pentazocine